EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study

Hiroshi Yokouchi iD, Hiroshi Nishihara, Yoshiyuki Kenmotsu, Kosuke Tsuji, Takayuki Kishikawa, Hajime Kikuchi, Eisaku Miyauchi, Yutaro Nagano iD, Kenya Kanazawa, Jun Sugisaka iD, Takayuki Ohkuri, Satoshi Oizumi

ImmunoTargets and Therapy · 2026-08 · Volume 15 · 1-15

DOI: 10.2147/itt.s585001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2026-08. Verfasst von Hiroshi Yokouchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

VISTAimmunohistochemical stainingmesotheliomanext-generation sequencingsurvival

Autor:innen und Institutionen

  • Department of Respiratory Medicine, NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
  • Center for Clinical Cancer Genomics and Precision Medicine, NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
  • Center for Cancer Genomics, Keio University School of Medicine, Tokyo, Japan.
  • Department of Internal Medicine, Kin-ikyo Chuo Hospital, Sapporo, Hokkaido, Japan.
  • Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Division of Thoracic Oncology, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan.

ORCID-Profile: Hiroshi Yokouchi, Yutaro Nagano, Jun Sugisaka

Zitieren

APA

Yokouchi, H., Nishihara, H., Kenmotsu, Y., Tsuji, K., Kishikawa, T., Kikuchi, H., Miyauchi, E., Nagano, Y., Kanazawa, K., Sugisaka, J., Ohkuri, T., & Oizumi, S. (2026). Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study. ImmunoTargets and Therapy, Volume 15, 1-15. https://doi.org/10.2147/itt.s585001

Vancouver

Yokouchi H, Nishihara H, Kenmotsu Y, Tsuji K, Kishikawa T, Kikuchi H, et al. Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study. ImmunoTargets and Therapy. 2026;Volume 15:1-15. doi:10.2147/itt.s585001

BibTeX
@article{Yokouchi2026,
  author = {Yokouchi, Hiroshi and Nishihara, Hiroshi and Kenmotsu, Yoshiyuki and Tsuji, Kosuke and Kishikawa, Takayuki and Kikuchi, Hajime and Miyauchi, Eisaku and Nagano, Yutaro and Kanazawa, Kenya and Sugisaka, Jun and Ohkuri, Takayuki and Oizumi, Satoshi},
  title = {Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study},
  journal = {ImmunoTargets and Therapy},
  year = {2026},
  volume = {Volume 15},
  pages = {1--15},
  doi = {10.2147/itt.s585001}
}
Kostenlos starten →